| abstract |
The invention relates to novel systematic or mucosal vaccine therapy means for certain cancers, viral infections and allergies. According to the invention, said means are supplied in the form of a family of composite superimmunogen compounds for bifunctional vaccine use which can induce an immune response that is directed against two different targets, namely the causal pathogen antigenic structure and the factors produced locally which are responsible for the subsequent neoangiogenic or immunotoxic stromal disorder. |